Catalent - Asia-Pacific clinical packaging facilities
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

25

May 2020

FDA approves Takeda's ALUNBRIG ® (brigatinib) as a first-line treatment for patients with rare and severe forms of lung cancer

Takeda Pharmaceutical Company Limited TSE NYSE TAK announced today that the US Food and Drug Administration FDA is approved for ALUNBRIG Brigatinib for adult patients with anaplastic lymphoma kinase ALK positive metastatic nonsmall cell lung cancer NSCLC which was diagnosed by an FDAapproved test...

23

May 2020

AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly

AbCellera announced that it has entered into a multiyear strategic research collaboration and license agreement with Eli Lilly and Company Lilly on the discovery of antibodies for up to nine Lillyselected therapeutic targets Lilly will have the rights to develop and commercialize therapeutic product...

22

May 2020

Kleo Pharmaceuticals and Celularity Enter into Research Collaboration

Kleo Pharmaceuticals Inc a leading company in the field of developing nextgeneration fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics and Celularity Inc a leading developer of allogeneic or offtheshelf natural killer NK cell therapies today announced a pr...

22

May 2020

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

GlaxoSmithKline plc and Samsung Biologics KS have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSKs innovative biopharmaceutical therapies

21

May 2020

Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins

Rentschler Biopharma SE a worldclass contract development and manufacturing organization CDMO for biopharmaceuticals and Horizon Discovery a global leader in the application of gene editing and gene modulation for cell line engineering today announced the signing of a commercial license agreement

21

May 2020

Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart

Kindred Biosciences Inc a biopharmaceutical company developing novel biologics announced it has entered into an agreement with Vaxart Inc Nasdaq VXRT for the manufacture of Vaxarts oral vaccine candidate for COVID

20

May 2020

Amplyx Pharmaceuticals Advances Development of Novel Antifungal, Fosmanogepix

Amplyx Pharmaceuticals a biotech company developing innovative therapies for debilitating and lifethreatening diseases in patients with compromised immune systems announced today that it has advanced development of its lead program fosmanogepix APX Enrollment has been completed in a Phase trial eva...

press releasesRead more...

23

May 2020

Zealand Pharma announces FDA acceptance of New Drug Application for the dasiglucagon HypoPal® rescue pen for treatment of severe hypoglycemia

Zealand Pharma AS a biotechnology company changing lives with innovative peptidebased medicines announced that the US Food and Drug Administration FDA has accepted for filing the companys New Drug Application NDA for the dasiglucagon HypoPal Rescue Pen for the treatment of hypoglycemia in people wi...

22

May 2020

Aquestive Therapeutics Advances Royalty Monetization Plan as Sunovion Pharmaceuticals’ Apomorphine Sublingual Film Therapy Receives FDA Approval

Aquestive Therapeutics Inc a pharmaceutical company focused on developing and commercializing differentiated products that address patients unmet needs and solve therapeutic problems today announced plans to advance its strategy to monetize the anticipated royalties associated with Sunovion Pharmace...

22

May 2020

Akari Therapeutics Receives Positive EMA Opinion on Orphan Designation for Nomacopan for Bullous Pemphigoid

Akari Therapeutics Plc Nasdaq AKTX a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where the complement C andor leukotriene LTB systems are implicated today announced that the European Medicines Agency EMA has issued a positive opin...

21

May 2020

Boragen Collaborates with Dole to Develop Boron-based Treatment for Major Banana Disease

Boragen Inc a worldleading boronbased discovery platform is proud to announce a collaboration with Dole Fresh Fruit Company a subsidiary of Dole Food Company Inc Dole is focused on finding innovative and more sustainable solutions to protect against Black Sigatoka one of the most prevalent and damag...

21

May 2020

FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients

The US Food and Drug Administration FDA has approved the investigational new drug IND application submitted by Octapharma USA for a phase three clinical trial on the efficacy and safety of Octagam Immune Globulin Intravenous Human therapy in COVID patients with severe disease progression

21

May 2020

Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for Coronavirus

Airway Therapeutics Inc a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases and Celonic Group a premium biopharmaceutical CDMO specialized in the development and production of Advance Th...

20

May 2020

ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions

ArcherDX Inc announced that the US Food and Drug Administration FDA has granted Breakthrough Device Designation for its nextgeneration sequencing NGS device under development as a companion diagnostic CDx to detect neurotrophic receptor tyrosine kinase NTRK gene fusions that lead to the formation an...

EventsRead more...

25 - 26

May 2020

LifeScience Micro MasterClass

Radisson Blu Park Royal Palace Hotel

25 - 26

May 2020

25 - 26

May 2020

27 - 28

May 2020

28 - 28

May 2020

11th Annual Clinical Trials Summit 2020

Virtue Insight
Kohinoor Continental Hotel

02 - 04

Jun 2020

02 - 04

Jun 2020

03 - 04

Jun 2020

Parkinson's and Movement Disorders

Pulsus Conference
Vienna

TOP ARTICLES

KNOWLEDGE BANK

  • Articles

    Pharmaceutical Component Kinetics

    Packaging Material PM components either primary secondary or tertiary are important for the medicinal product identity safety and stability despite they are not part of the dosage forms PM importance is evident from many recalls of drug products recorded in FDA database for various reasons such as mislabeling and contaminated materials

  • Research Insights

    Zika Virus Replicons For Drug Discovery

    Abstract The current epidemic of Zika virus ZIKV has underscored the urgency to establish experimental systems for studying viral replication and pathogenesis and countermeasure development Here we report two ZIKV replicon systems a luciferase replicon that can differentiate between viral translation and RNA synthesis and a stable luciferase replicon carr

  • Techno Trends

    First of its kind vaccine to control parasitic infection Leishmaniasis

    As scientists go through the rigmarole of getting a Zika virus vaccine into human trials a team of researchers is keen on preventing another insectborne disease called Leishmaniasis The researchers are working on a vaccine to control the spread of the disease in the Americas Researchers from Japan Brazil Canada and the United States have worked on altering the parasi...

  • White Papers

    Crippled by Cost? CMO Quo Vadis

    Introduction The global CMO market is said to reach USD billion by Patent expiry of drugs stringent price regulations especially in Europe US to purchase drugs from pharma companies Government budget cuts for pharma RD these are the forces which are expected to reshape the future of pharma and the CMO industry At least manufacturing facilities owned by pharma com...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...